Neurotrophic factors, cellular bridges and gene therapy for spinal cord injury
- PMID: 11351016
- PMCID: PMC2278599
- DOI: 10.1111/j.1469-7793.2001.0083b.x
Neurotrophic factors, cellular bridges and gene therapy for spinal cord injury
Abstract
Injury to the adult mammalian spinal cord results in extensive axonal degeneration, variable amounts of neuronal loss, and often severe functional deficits. Restoration of controlled function depends on regeneration of these axons through an injury site and the formation of functional synaptic connections. One strategy that has emerged for promoting axonal regeneration after spinal cord injury is the implantation of autologous Schwann cells into sites of spinal cord injury to support and guide axonal growth. Further, more recent experiments have shown that neurotrophic factors can also promote axonal growth, and, when combined with Schwann cell grafts, can further amplify axonal extension after injury. Continued preclinical development of these approaches to neural repair may ultimately generate strategies that could be tested in human injury.
Similar articles
-
Nerve growth factor-hypersecreting Schwann cell grafts augment and guide spinal cord axonal growth and remyelinate central nervous system axons in a phenotypically appropriate manner that correlates with expression of L1.J Comp Neurol. 1999 Nov 1;413(4):495-506. doi: 10.1002/(sici)1096-9861(19991101)413:4<495::aid-cne1>3.0.co;2-z. J Comp Neurol. 1999. PMID: 10495438
-
A combination of BDNF and NT-3 promotes supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord.Exp Neurol. 1995 Aug;134(2):261-72. doi: 10.1006/exnr.1995.1056. Exp Neurol. 1995. PMID: 7556546
-
Neurotrophins BDNF and NT-3 promote axonal re-entry into the distal host spinal cord through Schwann cell-seeded mini-channels.Eur J Neurosci. 2001 Jan;13(2):257-68. Eur J Neurosci. 2001. PMID: 11168530
-
Neurotrophic factors and gene therapy in spinal cord injury.Neurorehabil Neural Repair. 2000;14(4):265-75. doi: 10.1177/154596830001400403. Neurorehabil Neural Repair. 2000. PMID: 11402877 Review.
-
Schwann cells for spinal cord repair.Braz J Med Biol Res. 2005 Jun;38(6):825-35. doi: 10.1590/s0100-879x2005000600003. Epub 2005 Jun 1. Braz J Med Biol Res. 2005. PMID: 15933775 Review.
Cited by
-
Tubular scaffold with microchannels and an H-shaped lumen loaded with bone marrow stromal cells promotes neuroregeneration and inhibits apoptosis after spinal cord injury.J Tissue Eng Regen Med. 2020 Mar;14(3):397-411. doi: 10.1002/term.2996. Epub 2020 Jan 29. J Tissue Eng Regen Med. 2020. PMID: 31821733 Free PMC article.
-
Recombinant Adenoviruses for Delivery of Therapeutics Following Spinal Cord Injury.Front Pharmacol. 2022 Jan 10;12:777628. doi: 10.3389/fphar.2021.777628. eCollection 2021. Front Pharmacol. 2022. PMID: 35082666 Free PMC article. Review.
-
Recent Advances in Cell and Functional Biomaterial Treatment for Spinal Cord Injury.Biomed Res Int. 2022 Aug 8;2022:5079153. doi: 10.1155/2022/5079153. eCollection 2022. Biomed Res Int. 2022. Retraction in: Biomed Res Int. 2024 Jan 9;2024:9760680. doi: 10.1155/2024/9760680. PMID: 35978649 Free PMC article. Retracted. Review.
-
Minocycline Enhance the Restorative Ability of Olfactory Ensheathing Cells by the Upregulation of BDNF and GDNF Expression After Spinal Cord Injury.Basic Clin Neurosci. 2021 Nov-Dec;12(6):777-788. doi: 10.32598/bcn.2021.1727.1. Epub 2021 Nov 1. Basic Clin Neurosci. 2021. PMID: 35693138 Free PMC article.
-
Peripheral Nerve Healing: So Near and Yet So Far.Semin Plast Surg. 2021 Aug;35(3):204-210. doi: 10.1055/s-0041-1731630. Epub 2021 Sep 10. Semin Plast Surg. 2021. PMID: 34526869 Free PMC article. Review.
References
-
- Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. Journal of Neurotrauma. 1995;12:1–21. - PubMed
-
- Beattie MS, Li Q, Bresnahan JC. Cell death and plasticity after experimental spinal cord injury. Progress in Brain Research. 2000;128:9–21. - PubMed
-
- Blesch A, Diergardt N, Tuszynski MH. 28th Annual Meeting of the American Society For Neuroscience. CA, USA: Los Angeles; 1998. Cellularly delivered GDNF has robust chemotropic effects in the non-injured and injured adult rat spinal cord; p. 555.
-
- Blesch A, Uy HS, Diergardt N, Tuszynski MH. Neurite outgrowth can be modulated in vitro using a tetracycline-repressible gene therapy vector expressing human nerve growth factor. Journal of Neuroscience Research. 2000;59:402–409. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical